These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17297458)

  • 1. Nek3 kinase regulates prolactin-mediated cytoskeletal reorganization and motility of breast cancer cells.
    Miller SL; Antico G; Raghunath PN; Tomaszewski JE; Clevenger CV
    Oncogene; 2007 Jul; 26(32):4668-78. PubMed ID: 17297458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel association of Vav2 and Nek3 modulates signaling through the human prolactin receptor.
    Miller SL; DeMaria JE; Freier DO; Riegel AM; Clevenger CV
    Mol Endocrinol; 2005 Apr; 19(4):939-49. PubMed ID: 15618286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of NEK3 Kinase Threonine 165 as a Novel Regulatory Phosphorylation Site That Modulates Focal Adhesion Remodeling Necessary for Breast Cancer Cell Migration.
    Harrington KM; Clevenger CV
    J Biol Chem; 2016 Oct; 291(41):21388-21406. PubMed ID: 27489110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin-induced PAK1 tyrosyl phosphorylation promotes FAK dephosphorylation, breast cancer cell motility, invasion and metastasis.
    Hammer A; Diakonova M
    BMC Cell Biol; 2016 Aug; 17(1):31. PubMed ID: 27542844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition.
    Wang H; Quah SY; Dong JM; Manser E; Tang JP; Zeng Q
    Cancer Res; 2007 Apr; 67(7):2922-6. PubMed ID: 17409395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosyl phosphorylated serine-threonine kinase PAK1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion.
    Hammer A; Diakonova M
    Adv Exp Med Biol; 2015; 846():97-137. PubMed ID: 25472536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MST3 promotes proliferation and tumorigenicity through the VAV2/Rac1 signal axis in breast cancer.
    Cho CY; Lee KT; Chen WC; Wang CY; Chang YS; Huang HL; Hsu HP; Yen MC; Lai MZ; Lai MD
    Oncotarget; 2016 Mar; 7(12):14586-604. PubMed ID: 26910843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin.
    Chen HY; Shen CH; Tsai YT; Lin FC; Huang YP; Chen RH
    Mol Cell Biol; 2004 Dec; 24(24):10558-72. PubMed ID: 15572663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma.
    McHale K; Tomaszewski JE; Puthiyaveettil R; Livolsi VA; Clevenger CV
    Mod Pathol; 2008 May; 21(5):565-71. PubMed ID: 18246042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Rho-kinase affects astrocytoma morphology, motility, and invasion through activation of Rac1.
    Salhia B; Rutten F; Nakada M; Beaudry C; Berens M; Kwan A; Rutka JT
    Cancer Res; 2005 Oct; 65(19):8792-800. PubMed ID: 16204049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells.
    Paradiso A; Cardone RA; Bellizzi A; Bagorda A; Guerra L; Tommasino M; Casavola V; Reshkin SJ
    Breast Cancer Res; 2004; 6(6):R616-28. PubMed ID: 15535843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells.
    Nouhi Z; Chughtai N; Hartley S; Cocolakis E; Lebrun JJ; Ali S
    Cancer Res; 2006 Feb; 66(3):1824-32. PubMed ID: 16452244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin Signaling Stimulates Invasion via Na(+)/H(+) Exchanger NHE1 in T47D Human Breast Cancer Cells.
    Pedraz-Cuesta E; Fredsted J; Jensen HH; Bornebusch A; Nejsum LN; Kragelund BB; Pedersen SF
    Mol Endocrinol; 2016 Jul; 30(7):693-708. PubMed ID: 27176613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin as a chemoattractant for human breast carcinoma.
    Maus MV; Reilly SC; Clevenger CV
    Endocrinology; 1999 Nov; 140(11):5447-50. PubMed ID: 10537179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EHD2 mediates trafficking from the plasma membrane by modulating Rac1 activity.
    Benjamin S; Weidberg H; Rapaport D; Pekar O; Nudelman M; Segal D; Hirschberg K; Katzav S; Ehrlich M; Horowitz M
    Biochem J; 2011 Nov; 439(3):433-42. PubMed ID: 21756249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosyl phosphorylated PAK1 regulates breast cancer cell motility in response to prolactin through filamin A.
    Hammer A; Rider L; Oladimeji P; Cook L; Li Q; Mattingly RR; Diakonova M
    Mol Endocrinol; 2013 Mar; 27(3):455-65. PubMed ID: 23340249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAK1 regulates breast cancer cell invasion through secretion of matrix metalloproteinases in response to prolactin and three-dimensional collagen IV.
    Rider L; Oladimeji P; Diakonova M
    Mol Endocrinol; 2013 Jul; 27(7):1048-64. PubMed ID: 23744893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rac1 mediates phorbol 12-myristate 13-acetate-induced migration of glioblastoma cells via paxillin.
    Nomura N; Nomura M; Mizuki N; Hamada J
    Oncol Rep; 2008 Oct; 20(4):705-11. PubMed ID: 18813807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration.
    McShan GD; Zagozdzon R; Park SY; Zrihan-Licht S; Fu Y; Avraham S; Avraham H
    Int J Oncol; 2002 Jul; 21(1):197-205. PubMed ID: 12063569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing a relationship between prolactin and altered fatty acid β-oxidation via carnitine palmitoyl transferase 1 in breast cancer cells.
    Linher-Melville K; Zantinge S; Sanli T; Gerstein H; Tsakiridis T; Singh G
    BMC Cancer; 2011 Feb; 11():56. PubMed ID: 21294903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.